Hifu no kagaku
Online ISSN : 1883-9614
Print ISSN : 1347-1813
ISSN-L : 1347-1813
CLINICAL PHARMACOLOGY
Risk Factor Analysis of Hypercalcemic Cases Treated with Calcipotriol (Dovonex®)50μg/g Ointment-Presentation of Algorithm for Prevention
Takeshi Kono
Author information
JOURNAL RESTRICTED ACCESS

2007 Volume 6 Issue 2 Pages 209-216

Details
Abstract
Twenty cases with hypercalcemia, who were treated with calcipotriol (Dovonex®) ointment, were surveyed and risk factor of hypercalcemia was analyzed. Suspected risk factors are as follows : complication and history of renal disturbance, hypertension, hyperuricemia and diabetes ; combined administration of calcium, cyclosporin, etretinate, topical and systemic corticosteroid, other topical active vitamin D3 and emollient. Algorithm for prevention is presented.
Content from these authors
© 2007 Meeting of Osaka Dermatological Association/Meeting of Keiji Dermatological Association
Previous article
feedback
Top